Profil
Jason Barker served as Managing Director at Bauer York LLC from 2011 to 2015.
Prior to that, he was the Chief Accounting Officer & Head-Finance at ARYx Therapeutics, Inc. from 2009 to 2011.
He also served as the Chief Financial Officer at Zosano Pharma Corp.
Additionally, he briefly served as the Chief Financial Officer at Astellas Gene Therapies, Inc. in 2015.
In 2019, he became the VP, Chief Financial & Accounting Officer at Arcus Biosciences, Inc. Barker received his undergraduate degree from The University of Texas at Austin.
Anciens postes connus de Jason Barker
| Sociétés | Poste | Fin |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Directeur Financier/CFO | 01/08/2020 |
| AUDENTES THERAPEUTICS, INC. | Directeur Financier/CFO | 29/09/2015 |
| Bauer York LLC | Corporate Officer/Principal | 01/01/2015 |
| ARYX THERAPEUTICS, INC. | Directeur Financier/CFO | 09/07/2009 |
| ZOSANO PHARMA CORPORATION | Directeur Financier/CFO | - |
Formation de Jason Barker
| The University of Texas at Austin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARYX THERAPEUTICS, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
| Bauer York LLC | |
Zosano Pharma Corp.
 Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
